These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23485136)

  • 1. Diagnostic biomarkers of diabetic nephropathy.
    Ito H; Fujita H; Takahashi T
    Expert Opin Med Diagn; 2008 Feb; 2(2):161-9. PubMed ID: 23485136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC; Jandeleit-Dahm KA; Cooper ME
    Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in diabetic nephropathy--cause or consequence?
    Svensson M; Eriksson JW
    Diabetes Metab Res Rev; 2006; 22(5):401-10. PubMed ID: 16703644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery of biomarkers for type 2 diabetic nephropathy by serum proteome analysis.
    Cho EH; Kim MR; Kim HJ; Lee DY; Kim PK; Choi KM; Ryu OH; Kim CW
    Proteomics Clin Appl; 2007 Apr; 1(4):352-61. PubMed ID: 21136688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics in diabetic nephropathy.
    Kim HJ; Yoo HS; Kim CW
    Proteomics Clin Appl; 2008 Mar; 2(3):301-11. PubMed ID: 21136835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic nephropathy. A historical, clinical and diagnostic framework].
    Conti AA
    Minerva Med; 2002 Oct; 93(5):347-55. PubMed ID: 12410167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella N; George S
    Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.
    Currie G; Delles C
    Curr Diab Rep; 2016 Nov; 16(11):104. PubMed ID: 27658932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress in understanding the molecular pathogenesis of diabetic nephropathy].
    Abe H
    Rinsho Byori; 2011 Feb; 59(2):179-86. PubMed ID: 21476304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuminuria and diabetic nephropathy.
    Chang SS
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy].
    Yashima I; Hirayama T; Shiiki H; Kanauchi M; Dohi K
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):787-96. PubMed ID: 10655727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early urinary and plasma biomarkers for experimental diabetic nephropathy.
    Alter ML; Kretschmer A; Von Websky K; Tsuprykov O; Reichetzeder C; Simon A; Stasch JP; Hocher B
    Clin Lab; 2012; 58(7-8):659-71. PubMed ID: 22997966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic nephropathy.
    Ritz E
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetic nephropathy; clinical stage and prediction].
    Kaizu K; Komine N
    Rinsho Byori; 2001 Dec; 49(12):1205-11. PubMed ID: 11797389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of diabetic nephropathy in the proteomic era.
    Thongboonkerd V
    Contrib Nephrol; 2011; 170():172-183. PubMed ID: 21659770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases.
    Zhou J; Chen X; Xie Y; Li J; Yamanaka N; Tong X
    Nephrol Dial Transplant; 2008 Jun; 23(6):1940-5. PubMed ID: 18156459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Liu H; Hou X; Cheng J
    Nephrology (Carlton); 2009 Apr; 14(3):332-7. PubMed ID: 19143942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy.
    Zheng M; Lv LL; Cao YH; Zhang JD; Wu M; Ma KL; Phillips AO; Liu BC
    Clin Endocrinol (Oxf); 2012 May; 76(5):657-64. PubMed ID: 21824169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.